BioVersys AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.26	1.59	1.86
Net Debt / Equity Ratio	-1.06	-1.46	-1.45
Net Debt / EBITDA Ratio	4.18	0.84	0.71
Net Debt / FCF Ratio	4.42	1.00	1.06
Asset Turnover	-	0.04	-
Quick Ratio	9.02	3.51	3.25
Current Ratio	9.24	3.56	3.59
Return on Equity (ROE)	-	-194.40%	-
Return on Assets (ROA)	-	-33.87%	-
Return on Capital Employed (ROCE)	-21.00%	-74.10%	-71.40%
Buyback Yield / Dilution	-	-11.60%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.